Background. Incidence rates of renal replacement therapy (RRT) for end-stage renal disease vary considerably worldwide. This study examines the independent association between the general population, health care system and renal service characteristics and RRT incidence rates. Methods. RRT incidence data (2003)(2004)(2005) were obtained from renal registries; general population age and health and macroeconomic indices were collected from secondary sources. Renal service organization and resource data were obtained through interviews and questionnaires. Linear regression models were built to establish the factors independently associated with RRT incidence, stratified by the Human Development Index where required. False discovery rate (FDR) correction was adjusted for multiple testing. Results. Across the 46 countries (population 1.25 billion), RRT incidence rates ranged from 12 to 455 (median 130) per million population. Gross domestic product (GDP) per capita [incidence rate ratio (IRR): 1.02 per $1000 increase, P FDR ¼ 0.047], percentage of GDP spent on health care (IRR: 1.11 per % increase, P FDR ¼ 0.006) and dialysis facility reimbursement rate relative to GDP (IRR: 0.76 per GDP per capita-sized increase in reimbursement rate, P FDR ¼ 0.007) were independently associated with RRT incidence. In more developed countries, the private for-profit share of haemodialysis facilities was also associated with higher incidence (IRR: 1.009 per % increase, P FDR ¼ 0.003). Conclusions. Macroeconomic and renal service factors are more often associated with RRT incidence rates than measured demographic or general population health status factors.
Introduction
Chronic kidney disease (CKD) is now recognized to be a growing global public health problem fuelled by rising rates of diabetes mellitus, obesity, hypertension and ageing populations [1] . Although only a small proportion of patients progress to end-stage renal disease (ESRD), the chronic, resource-intensive nature of renal replacement therapy (RRT)-dialysis or kidney transplantation-makes this 0.1% of the population responsible for 1-2% of health care spending in high-income countries [2] . Since the development of RRT in the 1960s, state health care systems have had to decide how much of this life-sustaining treatment they are willing, and able, to pay for, sometimes very publicly [3, 4] .
The incidence of RRT, a measure of new cases of treated ESRD, is routinely collected by renal registries in many countries and shows a 45-fold variation across the world [5] . The extent to which this variation is associated with supply-side factors (macroeconomic, health care system and renal service organizational factors) rather than with demand-side factors (general population demographics and health status) has never been established, although narrative comparisons [6] and descriptive studies have been undertaken [7, 8] .
This study aims to establish the general population, health care system and renal service characteristics that are independently associated with incidence rates of RRT, an established but expensive medical technology, across the broad range of 46 countries participating in the EVEREST study [9] .
Materials and methods

Study design, setting and data sources
All national renal registries across the world that were known to have reported RRT data (n ¼ 51) were invited to take part in this study. If national-level registry data were unavailable, regional registries were approached. Local approval for collaboration in the study was obtained, where appropriate.
Some renal registries routinely provide individual patient RRT incidence data to the European Renal Association-European Dialysis and Transplantation Association (ERA-EDTA) Registry [9] . For all others, these data were collected specifically for the study through an electronic spreadsheet. Data were collected for all patients commencing RRT in each country, where available stratified in five gender-specific age bands (0-19, 20-44, 45-64, 65-74 and !75 years) [9] . Data were collected for the period 2003-2005 and averaged to minimize the impact of random variation. Incidence of RRT was defined as the number of patients commencing RRT during the study period. Total incidence of RRT and incidence of RRT for diabetic ESRD were collected at Day 1 of RRT [9] . Registries also provided data on the age and gender distribution of the general population they covered. Incidence rates per million population (p.m.p.) were calculated by dividing the observed counts by the covered general population.
Following a review of the literature and discussions with renal experts working in different health care systems around the world, a conceptual framework was constructed (available on request from the authors). This framework is summarized in Figure 1 . Three broad groups of data were identified: 'General population age and health indicators' and 'Macroeconomic indicators' (both collected from national and international secondary data sources [9] ) and 'Renal service organization indicators' (Box 1). Although a broad range of renal service factors potentially associated with the variation in RRT were initially identified and collected, only those based on locally available evidence, not opinion, have been included in this analysis. (The source of data-registry/centre survey/government or health department/personal estimate or opinion-was recorded in the questionnaires.) The identification of local data sources and the assessment of their validity required local knowledge and expertise; this was provided by recruiting an expert in renal services for each country. These national experts, defined as nephrologists with considerable experience and a national perspective in this area, were purposively sampled with the assistance and approval of national renal registries and, in most cases, the relevant national society of nephrology. A questionnaire (English language) was developed to collect the national expert data [9] . All data were collected between March 2008 and February 2009.
Full details of the methods adopted by the EVEREST study, including the full list of renal service variables originally collected and a list of the renal registry collaborators and national experts consulted, have been published separately [9] .
Statistical analysis
Descriptive statistics for continuous variables are reported as median, interquartile range (IQR) and range and for categorical variables as the percentage for each category. Poisson regression was not possible because of overdispersion of the data. Instead linear regression was performed. As incidence rates can only take positive values, a log transformation of the RRT incidence p.m.p. was used as the outcome variable in the regression analyses, where log is the natural logarithm. The estimated regression coefficients were then transformed back to the original scale and should be interpreted as incidence rate ratios (IRRs).
Regression analyses
The relationship between each predictor variable and the natural logarithm of RRT incidence p.m.p. was first studied using univariate linear regression. All necessary assumptions for linear regression were tested and found to be satisfied. To investigate the possibility of an independent relationship between each predictor variable and the incidence of RRT, an aetiological approach was adopted [11] . Separate models were constructed in turn taking one predictor variable at a time as the determinant while the other variables, if appropriate, were considered for inclusion as Fig. 1 . Summary of conceptual framework for RRT incidence. CVD ¼ cardiovascular disease; 1°¼ primary; 2°¼ secondary; Rx ¼ therapy. Reproduced with minor modification with permission from American Journal of Kidney Diseases [7] .
confounders. In order to qualify as a potential confounder, each variable needed to satisfy the criteria for confounding [12] . Even if not associated with the incidence of RRT, the following potential confounders were included on the basis that they were considered a priori to be important to adjust for: the age distribution and prevalence of diabetes mellitus in the general population and the public share of health care expenditure. Collinear confounders and confounders that caused <10% change in the b of the determinant were excluded from the model. As the number of observations was small (n ¼ 46), a maximum of four confounders could be included in the model for each determinant [13] . Therefore, for all qualifying potential and a priori confounders, the confounding effect in the relationship between the determinant and the outcome was investigated by calculating the percentage change in the b of the determinant after adding the potential confounder to the univariate linear regression model. Finally, for each determinant a multivariate linear regression model was constructed using the strongest four confounders.
Based on the prior hypothesis that the effect of factors would differ according to a nation's state of economic and social development, models in which United Nations Development Programme Human Development Index (HDI) was among the strongest four confounders were tested for interaction between HDI and the determinant. If the interaction term was significant (P < 0.10), countries were categorized as either high (n ¼ 23) or low (n ¼ 23) HDI (Box 2) and models were then rebuilt separately. This also provided a means of testing the generalizability of the results to all countries, regardless of their state of development. As diabetes mellitus might only be expected to influence rates of RRT attributable to diabetes, the relationship between general population diabetes prevalence and incidence of RRT for diabetic ESRD was examined separately.
As observations for the outcome and the determinants were based on groups of individuals (i.e. countries), the variability that must be taken into account is much smaller and the point estimates of coefficients much more precise than would be expected for an individual patient-level study of the same sample size. To reduce the risk of type I errors (i.e. false positives) associated with multiple testing, the Benjamini and Hochberg false discovery rate (FDR) adjustment was performed. P-values were corrected by controlling an FDR of 5% [14] . Data for certain general population health and macroeconomic indicators were unavailable for some countries, even from local sources; [9] these countries had to be excluded from models with these variables as either the determinant or the confounder.
Sensitivity analyses
To determine whether our results might have been influenced by the unavailability of age-standardized RRT incidence rates for all countries, a sensitivity analysis was performed including all high-HDI countries that had RRT incidence data available stratified into five age bands (n ¼ 21).
Statistical analyses were performed using SPSSÒ version 16.0 and SAS version 9.2.
Results
RRT incidence data for the years 2003-2005 were available for 46 of 51 countries (adult general population covered 1.25 billion), with rates ranging from 12 p.m.p. in Bangladesh to 455 p.m.p. in Taiwan (median RRT incidence 130 p.m.p., IQR 102-167 p.m.p.). These countries showed considerable heterogeneity of the general population, macroeconomic and renal service organization characteristics (Table 1) .
In the univariate analyses, each 0.1% increase in the general population cardiovascular mortality rate was associated with a 12% decrease in RRT incidence and each 1-year increase in life expectancy at 60 years was associated with a 12% increase in RRT incidence ( Table 2 ). The Box 1 General population age and health and macroeconomic indicators; for details of sources of the data for these variables, see Caskey et al. [9] ; missing data: diabetes prevalence (n ¼ 1), cardiovascular mortality (n ¼ 9), life expectancy at 60 years (n ¼ 7), health care expenditure as a % of GDP (n ¼ 1), responsiveness index (n ¼ 1), public share of health expenditure (n ¼ 1) prevalence of diabetes mellitus in the general population was not associated with RRT incidence. Of the macroeconomic factors, the HDI, GDP per capita, the proportion of GDP spent on health care and the responsiveness of the health care system were each positively associated with RRT incidence. Considering renal service factors, a doubling of the annual haemodialysis (HD) facility reimbursement rate relative to GDP per capita was associated with 32% lower RRT incidence. The private for-profit share of HD facilities was associated with higher RRT incidence but only in high-HDI countries.
In the multivariate models, life expectancy at 60 years was the only demographic factor independently associated with incidence of RRT (IRR 1.10 for each year of increase, 95% confidence interval 1.02-1.19, P ¼ 0.019) but not after correcting for FDR (P FDR ¼ 0.07) ( Table 2 ). Of the macroeconomic factors, GDP per capita and the proportion of GDP spent on health care were independently and positively associated with RRT incidence; the significance level of the positive association between RRT incidence and HDI did not reach 5% after correction for multiple testing. Considering the renal service organizational factors, a doubling of the annual HD facility reimbursement rate as a proportion of GDP per capita was associated with 24% lower RRT incidence. In high-HDI countries only, each 1% increase in the percentage of HD facilities owned by the private sector was associated with a 1% higher rate of RRT incidence.
Repeating analyses including only the 21 high-HDI countries with age-stratified data with age-standardized RRT incidence as the outcome provided similar results (data not shown). Analyses using RRT incidence for ESRD due to diabetes as the outcome variable found a positive independent association with general population diabetes prevalence that lost its statistical significance after correction for multiple testing (1.16 for each percent of increase, 1.02-1.33, P ¼ 0.025, P FDR ¼ 0.058, using the same confounders as in the overall RRT incidence model).
Discussion
This study examines, for the first time at a global level, the independent relationships between general population, macroeconomic, health care system and renal service organizational factors and RRT incidence. Four variables proved to be independently associated with RRT incidence-GDP per capita, the percentage of GDP spent on health care, the dialysis unit reimbursement rate and the private for-profit share of dialysis provision. However, there was no independent association between RRT incidence and any available population health status indicators.
A number of papers have described a univariate relationship between GDP and either incidence or prevalence of RRT [6, 15, 16] . Indeed, the 2008 WHO Bulletin reported an R 2 for the association between GDP per capita and RRT prevalence of 0.60 (i.e. 60% of variance in RRT prevalence explained by GDP per capita alone) [16] . Similar relationships have been found between macroeconomic variables and death due to avoidable diseases [17] and other medical procedures [18] . These associations were attributed to varying rates of diffusion of medical technology according to national wealth. The results of the present study show that this association with GDP is independent of the age and health of the populations being studied.
Although some authors have examined the relationship between the proportion of GDP spent on health care and spending on RRT [6] , to our knowledge no studies have to date looked at the association between the proportion of GDP spent on health care and RRT incidence. If data on ESRD incidence had been available, an increasing proportion of GDP spent on health care, if targeted effectively at prevention, should be associated with a decreasing ESRD incidence. Such data are not available, however, and the 11% increase in RRT incidence associated with each 1% increase in GDP spent on health care could be explained in one of two ways: either need is not being met in countries spending less on health care or need is being created in countries spending more on health care as a result of Box patients with diabetes and vascular disease surviving long enough to develop ESRD. The share of hospital beds owned by the private sector has been proposed as a proxy for the degree of state influence over health care providers [19] ; this measure was not available for all countries, so instead private for-profit share of HD facilities was used. There is one report describing a trend towards higher RRT incidence in countries whose dialysis provision is largely by the private sector [8] . It is interesting that despite adjusting for national wealth and the public share of health care expenditure, a 1% increase in the private for-profit share of HD facilities is still associated with a small (1%) but statistically significant higher incidence of RRT. A system that has more competition in the provision of HD facilities appears, therefore, to be associated with higher RRT incidence rates. A higher share of private HD facilities may be associated with a higher RRT incidence due to the incentives to treat that will be a feature of such systems. This might be reflected in earlier commencement of dialysis in the course of the disease (leadtime bias [20] [21] [22] [23] ) and greater readiness to employ dialysis in the older, comorbid patient in more competitive systems [24] [25] [26] [27] [28] . As with any reported association, however, alternative explanations-such as the higher rate of RRT leading to the higher share of private facilities-must not be forgotten. Although the negative association between HD facility reimbursement rate and RRT incidence may be explained by economies of scale (i.e. improved efficiency with increased activity), it may reflect the fact that HD facility reimbursement rate has been adjusted for GDP per capita to allow comparison between countries and GDP per capita itself is positively associated with RRT incidence.
The lack of an independent association between RRT incidence and a number of variables-general population age distribution, diabetes mellitus prevalence and the gatekeeper role of primary care-is surprising. Even in healthy individuals, kidney function declines slowly with age [29] and hypertension and diabetes, which are more prevalent in the elderly, add considerably to the risk of progression [30, 31] . It is therefore intuitive that countries whose inhabitants can expect to live longer when they reach 60 years (and have lower competing risk from death prior to reaching ESRD) should have higher rates of RRT. It must be remembered, however, that the analyses reported are restricted to treatment (RRT) and not disease (ESRD) rates and that the positive association observed would be consistent with more patients with ESRD receiving RRT.
The absence of an association between population diabetes prevalence and overall RRT incidence was unexpected given the findings of other national ecological studies [7, 32, 33] . One potential explanation for the lack of an association in the current study is a random misclassification of diabetes prevalence. Although 2003 estimates by the International Diabetes Federation based on published data [34] have been shown to be robust [35] , studies of various designs and methodology were included and missing prevalence rates for some countries were extrapolated from other similar countries. Further, estimates were only available for fairly current periods but patients commencing RRT were likely to have developed their diabetes mellitus 15-20 years ago [36, 37] . Another possible explanation is that diabetic nephropathy only represents a proportion of all incident RRT patients that varies markedly from 12% in Romania to 57% in Malaysia [5] . Nevertheless, diabetes prevalence in the general population was significantly associated with RRT incidence for diabetic ESRD in the 40 of 46 countries where available.
The finding that countries in which access to renal services is controlled by primary care (the so-called gatekeeper system) have RRT incidence rates comparable to those with open access may also be judged surprising. Earlier surveys had demonstrated that primary care and non-renal hospital physicians had higher thresholds for recommending dialysis than renal physicians [24, 25] . However, these differences in attitudes towards dialysis appear to have reduced, as more recent studies have shown [27] . Further, the ability of a gatekeeper system to control general health care spending is still hotly debated [38] .
Limitations
This study has involved the vast majority of countries with renal registries worldwide, but the national-level approach has meant that only 46 observations, albeit each of an entire general population, were available for analysis. The national approach also meant that within-country heterogeneity could not be captured and examined. However, even at a national level, standardized data on population health, macroeconomics and resources were difficult to obtain for some countries and this restricted the range of variables that could be included in the study. Renal service organizational data were collected from a single, senior, respected and locally approved, nephrologist in each country [9] . Although many of the data items initially requested of the national experts were subjective, this analysis has only included those that were based on locally available evidence and not on opinion. As with any observational study, only known and measurable confounders were included; the observed effects may still therefore be due to confounding by unknown or unmeasured variables. Data on CKD prevalence and ESRD incidence that could have been used to establish the real need for RRT were not available for the majority of countries.
In conclusion, while our data suggest that some general population age and health indicators do have an independent association with RRT incidence, macroeconomic and renal service organizational factors appear more important. The breadth of countries studied and the high rates of collaboration mean that these observations should be generalizable to all countries with national renal registries and provide the opportunity to generate hypotheses that will focus future studies into the causal nature of these relationships.
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